Serum nitric oxide metabolites in patients with multiple sclerosis

Journal of Clinical Neuroscience

Volumn 9, Issue 5, 2002, Pages 530-532

  Nazliel, B ^a   Taskiran D ^b,c   Irkec, C ^a   Kutay, F Z ^b,c   Poun S ^b,c  

^a GAZI UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY   (Turkey)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis (MS); Nitrate; Nitric oxide; Nitrite

Indexed keywords

MYELIN; NITRIC OXIDE;

ADULT; AGED; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0036746130     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2001.1077     Document Type: Article

References (25)

1. Raine CS. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994; 36: 61-72.
2. Merrill J, Ignarro L, Sherman M, Meinek J, Lana T. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-2141.
3. Mac Micking JD, Willenberg DO, Weidemann MJ, Rockett KA, Cowden WB. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis. J Exp Med 1992; 176: 303-307.
4. Synder SH. Nitric oxide: first in a new class of neurotransmitters. Science 1992; 257: 494-496.
5. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993; 268: 12231-12234.
6. Dawson TM, Dawson VL, Synder SH. A novel neuronal messenger molecule in brain: the free radical nitric oxide. Int J Neurosci 1992; 32: 297-311.
7. Giovannoni G, Heales SJ, Land JM, Thompson EJ. The potention role of nitric oxide in multiple sclerosis. Mult Scler 1998; 4: 212-216.
8. Poser CM, Paty D, Scheinberg L. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983: 13: 227-231.
9. Taskiran D, Sagduyu A, Yuceyar N, Kutay FZ, Pogun S. Increased cerebrospinal fluid and serum nitrite and nitrate levels in Amyotrophic Lateral Sclerosis. Int J Neurosei 2000; 101: 65-72.
10. Rainc CS. Demyelinating diseases. Textbook of Neuropathology. Baltimore: Williams and Wilkins. 1991: 535.
11. Adams CW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977: 33: 15-20.
12. Wynn DR, Rodriquez M, O'Fallon WM, Kurtland LT. Update on the epidemiology of multiple sclerosis. Mayo Clin Proc 1989: 64: 808- 881.
13. Allen I. Aetiological hypotheses for multiple sclerosis: Evidence from human and experimental diseases. Mc Alpine's Multiple Sclerosis. Edinburgh: Churchill Livingstone, 1991: 379-390.
14. Poser CM. Multiple sclerosis observations and reflections. A personal memoir. J Neurol Sci 1992: 107: 127-140.
15. de Grooth CJ, Ruuls SR, Theewes JW, Dikstre DC. Immunochemical charecterization of expression of inducible and constitituve isoform of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997; 56: 10-20.
16. Sherman MP, Griscavage JM, Ignarro LJ. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses 1992: 39: 143-146.
17. Koprowski H, Zhang YM, Heber-Kastz E. et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic disease. Proc Natl Acad Sci USA 1993: 90: 3024-3027.
18. Boullerne AI, Petry KG, Meynard M, Geffard M. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrocysteine. J Neuroimmunol 1995: 60: 117-124.
19. Bö L. Dawson TM, Wesselingh S. et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 336: 778-786.
20. Tran EH, Hardin-Pouzet H, Varge G, Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J Neuroimmunol 1997: 74: 121-129.
21. Yamashita T, Ando Y, Obayashi K, Uchino M, Ando M. Changes in nitrite and nitrate levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 1997; 153: 32-34.
22. Johnson AW, Land JM, Thompson EJ, Bolanos JP, Clark JB, Heales SJ. Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatr 1995; 58: 107-112.
23. Brundin L, Morcos E, Olsson T, Wiklund NP, Andersson M. Increased intrathechal nitric oxide formation in multiple sclerosis: Cerebrospinal fluid nitrite as activity marker. Eur J Neurol 1999; 6: 585-590.
24. Giovannoni G, Heales SJ, Silver NC. Raised serum nitrite and nitrate levels in patients with multiple sclerosis. J Neurol Sci 1997; 145: 77-81.
25. de Bustos F, Navarro JA, de Andres C. et al. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis. Eur Neurol 1999; 41: 44-7.